source
- Industry insiders invited to take Q3 BioPharma Sentiment SurveySignal's Endpoints team is launching the third quarterly BioPharma Sentiment Index (BPSI) survey, a three minute questionnaire that captures industry views. The survey asks participants to share p…
- AstraZeneca’s oral relaxin drug shows partial success in mid-stage heart-failure trialAstraZeneca reported that its oral relaxin agonist improved cardiac function in a subset of patients enrolled in a mid-stage heart‑failure study. The trial demonstrated measurable benefits for some…